PE20030145A1 - AN A2A AGONIST IN COMBINATION WITH AN ANTICHOLINERGIC AGENT FOR THE TREATMENT OF OBSTRUCTIVE DISEASES OF THE VIAS AREAS - Google Patents

AN A2A AGONIST IN COMBINATION WITH AN ANTICHOLINERGIC AGENT FOR THE TREATMENT OF OBSTRUCTIVE DISEASES OF THE VIAS AREAS

Info

Publication number
PE20030145A1
PE20030145A1 PE2002000439A PE2002000439A PE20030145A1 PE 20030145 A1 PE20030145 A1 PE 20030145A1 PE 2002000439 A PE2002000439 A PE 2002000439A PE 2002000439 A PE2002000439 A PE 2002000439A PE 20030145 A1 PE20030145 A1 PE 20030145A1
Authority
PE
Peru
Prior art keywords
amino
diphenylethyl
purin
methyl
agonist
Prior art date
Application number
PE2002000439A
Other languages
Spanish (es)
Inventor
Michael Yeadon
Roisin A Armstrong
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0129275A external-priority patent/GB0129275D0/en
Priority claimed from GB0210238A external-priority patent/GB0210238D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of PE20030145A1 publication Critical patent/PE20030145A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE REFIERE A UNA COMBINACION DE INHALACION DE UN AGONISTA SELECTIVO DEL RECEPTOR ADENOSINA A2a TAL COMO N-({9-[(2R,3R,4S,5R)-3,4-DIHIDROXI-5-(METOXIMETIL)TETRAHIDRO-2-FURANIL]-6-[(2,2-DIFENILETIL)AMINO]-9H-PURIN-2-IL}-METIL)-2-METIL-1-PROPANOSULFONAMIDA; CIS-(2R,3R,4S,5R)-2-(6-[(2,2-DIFENILETIL)AMINO]-2-{[(4-ISOPROPILCICLOHEXIL)AMINO]METIL}-9H-PURIN-9-IL)-5-(METOXIMETIL)TETRAHIDRO-3,4-FURANODIOL Y TRANS-(2R,3R,4S,5R)-2-(6-[(2,2-DIFENILETIL)AMINO]-2-{[(4-ISOPROPILCICLOHEXIL)AMINO]METIL}-9H-PURIN-9-IL)-5-(METOXIMETIL)TETRAHIDRO-3,4-FURANODIOL, 6-[(2,2-DIFENILETIL)AMINO]-9-{(2R,3R,4S,5S)-5-[(ETILAMINO)CARBONIL]-3,4-DIHIDROXITETRAHIDRO-2-FURANIL}-N-(2-[({[1-(2-PIRIDINIL)-4-PIPERIDINIL]AMINO}CARBONIL)AMINO]ETIL}-9H-PURIN-2-CARBOXAMIDA; ENTRE OTROS Y UN AGENTE ANTICOLINERGICO QUE NO ES UNA SAL DE TIOTROPIO Y PUEDE SER UNA SAL DE IPRATROPIO O UNA SAL DE OXITROPIO. LA COMBINACION SINERGICA DE UN ANTAGONISTA DEL RECEPTOR MUSCARINICO JUNTO CON UN AGONISTA A2A A TRAVES DE LA INHALACION NO PROVOCA EFECTOS PERIFERICOS NO DESEADOS Y PUEDE SER UTIL PARA EL TRATAMIENTO DE UNA ENFERMEDAD OBSTRUCTIVA DE LAS VIAS AEREAS, OTRA ENFERMEDAD INFLAMATORIAREFERS TO AN INHALATION COMBINATION OF A SELECTIVE AGONIST OF THE ADENOSINE A2a RECEPTOR SUCH AS N - ({9 - [(2R, 3R, 4S, 5R) -3,4-DIHYDROXY-5- (METOXIMETHYL) TETRAHYDRO-2-FURANIL ] -6 - [(2,2-DIPHENYLETHYL) AMINO] -9H-PURIN-2-IL} -MEthyl) -2-METHYL-1-PROPANOSULFONAMIDE; CIS- (2R, 3R, 4S, 5R) -2- (6 - [(2,2-DIPHENYLETHYL) AMINO] -2 - {[(4-ISOPROPYL CYCLOHEXYL) AMINO] METHYL} -9H-PURIN-9-IL) -5- (METOXIMETHYL) TETRAHYDRO-3,4-FURANODIOL AND TRANS- (2R, 3R, 4S, 5R) -2- (6 - [(2,2-DIPHENYLETHYL) AMINO] -2 - {[(4-ISOPROPYL CYCLOHEXIL ) AMINO] METHYL} -9H-PURIN-9-IL) -5- (METOXIMETHYL) TETRAHYDRO-3,4-FURANODIOL, 6 - [(2,2-DIPHENYLETHYL) AMINO] -9 - {(2R, 3R, 4S , 5S) -5 - [(ETHYLAMINE) CARBONYL] -3,4-DIHYDROXYTETHYDRO-2-FURANIL} -N- (2 - [({[1- (2-PYRIDINYL) -4-PIPERIDINYL] AMINO} CARBONYL) AMINO ] ETHYL} -9H-PURIN-2-CARBOXAMIDE; BETWEEN OTHERS AND AN ANTICHOLINERGIC AGENT WHICH IS NOT A THOOTROPE SALT AND MAY BE AN IPRATROPIUM SALT OR AN OXYTHROPIUM SALT. A2A AGONIST THROUGH INHALATION DOES NOT CAUSE UNWANTED PERIPHERAL EFFECTS AND MAY BE USEFUL FOR THE TREATMENT OF AN OBSTRUCTIVE AIRWAY DISEASE, OTHER INFLAMMATORY DISEASE

PE2002000439A 2001-05-25 2002-05-24 AN A2A AGONIST IN COMBINATION WITH AN ANTICHOLINERGIC AGENT FOR THE TREATMENT OF OBSTRUCTIVE DISEASES OF THE VIAS AREAS PE20030145A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29384201P 2001-05-25 2001-05-25
GB0129275A GB0129275D0 (en) 2001-12-06 2001-12-06 Pharmaceutical combination
GB0210238A GB0210238D0 (en) 2002-05-03 2002-05-03 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
PE20030145A1 true PE20030145A1 (en) 2003-03-01

Family

ID=42632507

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2002000439A PE20030145A1 (en) 2001-05-25 2002-05-24 AN A2A AGONIST IN COMBINATION WITH AN ANTICHOLINERGIC AGENT FOR THE TREATMENT OF OBSTRUCTIVE DISEASES OF THE VIAS AREAS

Country Status (4)

Country Link
AR (1) AR036030A1 (en)
EA (1) EA200301153A1 (en)
PE (1) PE20030145A1 (en)
TN (1) TNSN03124A1 (en)

Also Published As

Publication number Publication date
EA200301153A1 (en) 2004-04-29
AR036030A1 (en) 2004-08-04
TNSN03124A1 (en) 2005-12-23

Similar Documents

Publication Publication Date Title
PE20011122A1 (en) PURINE-2-ILCARBOXAMIDE DERIVATIVES AS SELECTIVE AGONISTS OF THE ADENOSINE A2a RECEPTOR
CO5601022A2 (en) METHODS TO TREAT PATIENTS WHO ARE MOVING DISORDERS
AR068879A1 (en) ORGANIC COMPOUNDS
JP2018522038A5 (en)
CO5540324A2 (en) AN A2A AGONIST IN COMBINATION WITH AN ANTI-POLINERGIC AGENT FOR THE TREATMENT OF AIRWAY OBSTRUCTIVE DISEASES
JP2008517057A5 (en)
RU2007137990A (en) Adenosine Derivatives With A2A Receptor Activity
MEP35308A (en) COMPOUNDS SPECIFIC TO ADENOSINE A1, A2a, AND A3 RECEPTOR AND USES THEREOF
JP2007536277A5 (en)
JP2007523178A5 (en)
JP2009500443A5 (en)
MA29799B1 (en) ADMINISTRATION OF DIPEPTIDYL PEPTIDASE INHIBITORS
AR041089A1 (en) PROCEDURE AND PHARMACEUTICAL COMPOSITIONS TO TREAT ATEROSCLEROSIS, DYSLIPIDEMIAS AND RELATED AFFECTIONS
JP2009501746A5 (en)
WO2022251663A2 (en) Novel universal anti-rna virus agents
NO20066012L (en) Purine derivatives such as adenosine A1 receptor agonists and methods for their use
PE20071230A1 (en) COMBINATIONS AND METHODS OF HCV INHIBITORS
RU2018106886A (en) COMBINED THERAPIES FOR TREATMENT OF CANCER
JP2002539224A5 (en)
Peart et al. Receptor and non-receptor-dependent mechanisms of cardioprotection with adenosine
Cargnoni et al. Role of A2A receptor in the modulation of myocardial reperfusion damage
PE20030145A1 (en) AN A2A AGONIST IN COMBINATION WITH AN ANTICHOLINERGIC AGENT FOR THE TREATMENT OF OBSTRUCTIVE DISEASES OF THE VIAS AREAS
PE20070622A1 (en) ADMINISTRATION OF DIPEPTIDYL PEPTIDASE INHIBITORS
Haywood et al. Role of the purinergic signaling network in lung ischemia-reperfusion injury
AR039977A1 (en) DICLOFENAC BASED COMPOSITION FOR THE TOPICAL TREATMENT OF OROPHARINGEA CAVITY AFFECTIONS

Legal Events

Date Code Title Description
FA Abandonment or withdrawal